Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.445 CAD | -1.11% | +1.14% | +4.71% |
Apr. 10 | Spectral Medical Updated on Tigris Trial | MT |
Apr. 10 | Spectral Medical Brief: Providing Tigris Trial Update; 101 patients enrolled | MT |
Sales 2024 * | 1.4M 1.03M | Sales 2025 * | 2.5M 1.83M | Capitalization | 126M 92.07M |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | - | EV / Sales 2024 * | 89.8 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 50.3 x |
P/E ratio 2024 * |
-11.3
x | P/E ratio 2025 * |
-22.5
x | Employees | 29 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 66.49% |
Latest transcript on Spectral Medical Inc.
1 day | +5.88% | ||
1 week | +2.27% | ||
Current month | -4.26% | ||
1 month | -2.17% | ||
3 months | -11.76% | ||
6 months | +40.62% | ||
Current year | +5.88% |
Managers | Title | Age | Since |
---|---|---|---|
Chris Seto
CEO | Chief Executive Officer | - | 19-08-01 |
Paul Walker
CHM | Chairman | - | 01-03-31 |
John Kellum
CTO | Chief Tech/Sci/R&D Officer | - | 21-02-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Paul Walker
CHM | Chairman | - | 01-03-31 |
Anthony Bihl
BRD | Director/Board Member | 67 | 08-02-29 |
Janelle D'Alvise
BRD | Director/Board Member | 69 | 21-11-11 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 0.445 | -1.11% | 3 522 |
24-04-25 | 0.45 | +5.88% | 26,100 |
24-04-24 | 0.425 | -3.41% | 6,500 |
24-04-23 | 0.44 | +2.33% | 12,068 |
24-04-22 | 0.43 | -2.27% | 14,910 |
Delayed Quote Toronto S.E., April 25, 2024 at 03:16 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+5.88% | 91.78M | |
+25.23% | 556B | |
-6.33% | 354B | |
+19.90% | 331B | |
+7.95% | 296B | |
+13.00% | 233B | |
+5.29% | 201B | |
-10.35% | 193B | |
-12.26% | 143B | |
-6.47% | 144B |
- Stock Market
- Equities
- EDT Stock